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Introduction. Since it is still controversial whether-low-to mod-
erate long-term lead below current threshold values causes neu-
robehavioural deficits in adults. 
Methods. Forty lead-exposed workers subjects with a mean blood 
lead (PbB) level of 56.4  µg/dL and 40 non-lead-exposed aged 
matched subjects (PbB: 15.4 µg/dL) with the same socio-economic 
background were investigated. Participants were administered a 
neuropsychological tests consisting of BAMT (Branches Alternate 
Movements Task), FT (Finger Tapping Speed), DS (Digit Span) 
POMS (Profile of Mood States).
Results. Authors noted a significant relationship between the 
exposed and the referent groups in tests mainly involving executive 
functions, short time memory and psycho-emotional variables. In 
addition, Poisson regression test performed on single psycho-
emotional factors (POMS), has allowed to evidence a significant 
influence of Pb e ZPP levels on tension, anxiety and depression.
Conclusions. The present study showed that lead exposure among 
adults at levels previously considered safe, results in impairment 
of certain cognitive abilities.
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Summary
Introduction
Lead (Pb) is a metal with many important industrial 
uses. Occupational exposure to lead can produce toxic 
effects on multiple organ systems including renal dys-
function, hematopoietic diseases, neurocognitive and 
reproductive disorders. Although occupational exposure 
to this neurotoxic agent has declined steadily over the 
past 20 years, the presence of lead in occupational set-
tings continues to be a source of both acute and chronic 
exposure, resulting in blood levels ranging 40 to 120 µg/
dL, as demonstrated by the Agency for Toxic Substances 
and Disease Registry [1].
Several studies showed an association between lead and 
cognitive abilities in children at blood levels even below 
10 µg/dL without evidence of a safe lower threshold [2].
In 2015, United States National Institute for Occupa-
tional Safety and Health (NIOSH) indicated 5 µg/dL as 
the reference blood lead level (PbB) for adults. Nonethe-
less, the U.S. Occupational Safety and Health Admin-
istration (OSHA) recommends to remove workers from 
lead exposure when PbB is above 60 µg/dL and readmit 
them when it is below 40 µg/dL. Moreover, the Ameri-
can Conference of Governmental Industrial Hygienists 
(ACGIH) suggests a biological exposure index of 30 µg/
dL for workers.
Workers exposed to lead often show impaired perfor-
mance on neurobehavioral test involving attention, pro-
cessing, speed, visuospatial abilities, working memory 
and motor function. It has also been suggested that lead 
can adversely affect general intellectual performance [3].
Exposure to inorganic lead in the environmental and 
occupational settings continues to be a serious public 
health problem. At high exposure levels, lead causes en-
cephalopathy, kidney damage, anaemia and toxicity to 
the reproductive system. Even at lower doses, lead pro-
duces alterations in cognitive development in children 
and adults. A really safe level for lead exposure has not 
been defined, as health risks associated with this metal 
have been shown even at very low doses [4].
Recent meta–analyses reported worse neurobehavio-
ral performances for exposed than unexposed workers 
with PbB levels lower than 50-60  µg/dL. The authors 
concluded that none of the individual studies were con-
clusive or adequate in providing information on the ef-
fects of lead on cognitive function  [5-7]. Furthermore, 
mild cognitive impairment (MCI) is considered to be a 
high-risk state for developing dementia with about 50% 
of MCI patients progressing to dementia [8]. However, 
several lines of evidence have now suggested that envi-
ronmental exposure to lead may play an important role. 
A recent study investigating cumulative lead exposure 
and cognitive function in adult men reported that the de-
gree of performance impairment over time, particularly 
in visuospatial and visuomotor domains, increased with 
increasing bone lead concentration, a marker of cumu-
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lative exposure  [9]. Recent animal studies report that 
early developmental lead exposure in rodents resulted 
in an age-related elevation in amyloid precursor protein 
(APP) and its amyloidogenic Aβ product, markers of 
Alzheimer’s Disease (AD) [10, 11] and over-expression 
of the β-amyloid protein precursor gene 20 months after 
exposure had ceased. Subsequent studies in non-human 
primates that were exposed to lead during development 
have shown similar effects [12]. Furthermore, lead may 
be indirectly linked to dementia through its demonstrat-
ed hypertensive effect [13-16], a risk factor considered 
to play an important role in the development of demen-
tia  [17]. In addition, lead could act on neurotransmis-
sion, such as the acetylcholine system which is known 
to be compromised in AD [18, 19]. One limitation of the 
current understanding of the potential risk posed by lead 
exposure for dementias or MCI is the lack of informa-
tion on the specific behavioural profile with which lead 
may be associated. In particular, it is unknown whether 
lead exposure reproduces the specific behavioural def-
icits, many of which can also be directly evaluated in 
experimental animal models, that have proven to be pre-
dictive of dementias in human. The present study was 
conducted to evaluate the association between occupa-
tional lead exposure and MCI using biological markers 
and validated behavioural measures.
Materials and methods
The present study was carried out at the Occupational 
Health Institute, Medical School, University of Messina, 
Italy.
Forty male workers, employed in a battery recycling 
plant placed in Messina, Italy, responders to an invita-
tion to participate in the health surveillance program, 
fulfilled the inclusion criteria for the present study. 
Inclusion criteria were: living in Messina metropolitan 
area, working in the battery storage plant for at least 5 h/
day, willing and able to attend required study visits, lack 
of any systemic disease. Workers under medication with 
both cerebro-active drugs and any other substances able 
to interfere with neuro-behavioural performances were 
excluded from the study. 
A total of forty workers, with mean age of 37.15 years 
(SD ± 8.09), matched the inclusion criteria. The control 
group included forty healthy male subjects with no pre-
sent or past exposure to lead, age-matched, chosen from 
people working in several offices located in the urban 
area of Messina. Informed consent was obtained from 
workers.
All participants were interviewed by well-trained oc-
cupational physicians, and information about socio-
demographic characteristics, disease history, alcohol 
consumption, cigarette smoking, dietary patterns (ethnic 
products intake), residential area (presence of nearby in-
dustries or factories), occupational history (of the last 3 
years for possible lead-exposing occupation) were gath-
ered.
Cognitive and behaviour measures were administered to 
workers by a specialist in clinical psychology after the 
working shift, in a standardized environment and using 
uniform procedures.
The evaluation of both biomarkers of exposure and ef-
fect (blood lead, PbB; aminolevulinate dehydratase, 
ALAD; Zn protoporphirin, ZPP; haemoglobin, Hb) and 
psychological tests in the exposed workers with respect 
to non exposed subjects was performed. 
Environmental assessment of workplace lead levels was 
given by factory management and was over the threshold 
limit value of 0.05 mg/m3 set by the ACGIH [20].
Biological monitoring
Venous blood samples were taken for the determination 
of lead dose (PbB) and effect (Hb, ALAD and ZPP) bio-
markers. 
The whole blood specimens were collected using a lead-
free heparinized evacuated tubes. Blood samples were 
stored at +4°C until the analysis, which was performed 
within 2 weeks. 
Psycho-diagnostic protocol 
BAMT (Branches Alternate Movements Task) was per-
formed on all subjects to assess motor coordination [21]. 
Subjects alternatively touch their knees crossing arms 
and the sequence is repeated alternatively for 30 sec-
onds.
FT (Finger Tapping) speed measures the maximum num-
ber of repetitive movements made beating as quickly as 
possible a button with the index finger, holding the arm 
supported in a fixed position and comfortable and alter-
nating hands (dominant/non-dominant) for a total of 6 
tests in 10 seconds [22].
DS (Digit Span), a simple traditional evaluation of short 
term memory: a series of numbers, each time increasing 
in length, is repeated forwards and in reverse order. Sub-
test is on the basis of correct answers [23].
Profile of Mood States (POMS), administrable to adults 
with compulsory education in a maximum range of time 
of 10 minutes, in the Italian version is made up of 58 
items that define the six factors of mood [24]:
• Tension-Anxiety = T
• Depression-Dejection = D
• Anger-Hostility = A
• Vigor-Activity = V
• Fatigue-Inertia = F
• Confusion-Bewilderment = C
To get the score of each of the six factors, the scores of 
the single answers to each single item that define the 
score itself are added to every item. 0,1,2,3 or 4 points 
are given except for the two terms “relaxed” in the scale 
Confusion-Bewilderment that must be inverted in the as-
signment result (4,3,2,1 or 0). The factor Vigor-Activity 
is evaluated with a negative sign and referred to male 
sex. The rough scores are converted into standard ones.
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Statistical analysis
Statistical analysis was performed using the Statisti-
cal Package for the Social Science the Methodologi-
cal S.R.L. NPC Test  [25, 26]; the Minitab Release 
13.31 [27] and R 2.1.1 [28] for the estimation of Poisson 
regression. 
Descriptive variables were evaluated for differences 
between means for continuous variables and with non 
parametric analysis for not continuous variables.
The differences of both lead exposure indices and psy-
chological tests between the group under study and 
the control group were analysed by Student’s unpaired 
t test. Furthermore, correlation between lead exposure 
biomarkers and seniority and Hb level were tested using 
Pearson’s linear correlation test.
In order to analyze the influence of lead exposure on 
neurobehavioral test (BAMT, FT, DS with Direct and In-
verse Digitations) a multivariate ordinal logistic regres-
sion was performed because the scores of the neurobe-
havioral tests constitute ordinal categorical variables.
The influence of exposure to lead on the performance 
levels of each psycho-emotional test (POMS) was tested 
through the estimation of a generalized linear model of 
Poisson because the scores of the POMS are discreet 
and not negative. The fixed level of significance for the 
whole statistical analysis was p < 0.005.
Results
The socio-demographic characteristics and biomarkers 
of exposed and non exposed workers are shown in Ta-
ble I. PbB and ZPP mean levels were significantly high-
er in exposed than in non exposed workers. As expected, 
the mean value of ALAD was significantly lower in 
exposed than non exposed workers. A PbB level higher 
than the threshold limit value (60 mg/dL) was found in18 
(45%) of the exposed workers. Current blood lead level 
(PbB) of the exposed workers ranged from 24 to 76 μg/
dL. PbB of the controls ranged from 13 to 18 μg/dL.
Regarding to considered whole psycho-emotional vari-
ables, the authors evidenced significant differences be-
tween the two groups. The results of neuroemotional 
variables are showed in Table II. The values of tension, 
depression, aggressiveness, tiredness and confusion, re-
sulted higher in the exposed workers than the controls. 
An inverse direction was found for the vigour, that re-
sulted higher for the controls with respect to the exposed 
workers (Tab. II).
Tab. I. Socio-demographic characteristics and biomarkers of lead exposure and effect in exposed and non-exposed workers.
Exposed Controls p <
Population under study 40 40 NS
Age (years, mean ± SD) 37.15 ± 8.09 37.3 ± 8.1 NS
Education (years, mean ± SD) 15.3 ± 2.73 12.0 ± 1.7 NS
Seniority (years, mean ± SD) 4.3 ± 2.05 4.6 ± 1.8 NS
Alcohol consumption
None



















PbB (μg/dL, mean ± SD) 56.4 ± 14.4 15.4 ± 1.5 0.005
ZPP (µg/dL, mean ± SD) 53.8 ± 22.9 23.4 ± 1.4 0.005
ALAD (u/ml, mean ± SD) 28.2 ± 9.4 58.0 ± 1.9 0.005
Tab. II. Comparison of neuro-behavioural and psycho-emotional variables (mean ± SD of score) between exposed and non exposed workers. 
Exposed Controls p <
NEURO-BEHAVIORAL VARIABLES
BAMT 3.8 ± 1.1 4.4 ± 0.5 0.005
Fingers 3.8 ± 1.0 4.7 ± 0.5 0.005
Direct Digitation 5.5 ± 0.8 5.5 ± 0.8 NS
Inverse Digitation 3.5 ± 0.7 4.9 ± 0.4 0.005
PSICO-EMOTIONAL VARIABLES
Tension 58.3 ± 9.1 50.6 ± 6.7 0.005
Depression 57.0 ± 10.6 48.3 ± 7.2 0.005
Aggressiveness 54.2 ± 9.9 47.2 ± 7.9 0.005
Vigor 57.0 ± 6.1 68.2 ± 3.7 0.005
Tiredness 61.2 ± 11.0 50.4 ± 7.3 0.005
Confusion 62.6 ± 11.4 51.5 ± 7.4 0.005
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Table III shows correlation between biomarkers of lead 
exposure and effect and both seniority and Hb concen-
tration in the groups under study. Seniority was inversely 
correlated to the PbB level while ZPP was negatively 
correlated to the working age.
The estimation of ordinal logistic regression model 
(gompit was the used link function) has allowed to 
evaluate the influence of some variables on the scores 
obtained by neurobehavioral tests. Table IV reports the 
estimation of two models of ordinal logistic regression: 
in the first model the answer variable is BAMT, that im-
plies a score ranging from 1 to 5. In the exposed subjects 
it assumes the value 1 in 2 cases (5%), value 2 in 2 cases 
(5%), value 3 in 10 cases (25%), 4 in 14 cases (35%), 5 
in 12 cases (30%), so that the presence of four constants 
was evidenced in the model.
In the second model the answer variable is FINGERS, 
that requires a score ranging from 1 to 6. In the exposed 
group it assumes the value 1 in any case (0%), value 2 
in 4 cases (10%), value 3 in 14 cases (35%), value 4 in 
10 cases (25%), value 5 in 12 cases (30%);no case with 
value 6 was found. Therefore the model includes three 
constants.
As showed in Table IV, the BAMT is significantly de-
pendent from PbB level (the number of correct move-
ments of exposed subjects decreases with the increase 
of lead levels); the variable FINGERS is dependent on 
working age: the number of correct movements per-
formed with the fingers decreases as the number of years 
of exposure increases.
Finally, the Poisson regression performed on the levels 
of performance of the single psycho-emotional tests 
(POMS) has allowed to underline that the levels of PbB 
and ZPP significantly influence the tension and the de-
pression (Tab. V).
Discussion and conclusions
The findings of the present study showed that occupa-
tional lead exposure results in impairment of certain 
cognitive abilities at levels considered safe by certain 
scientific committees. At a mean PbB of 56.4 μg/dL, we 
observed a significant relationship between the exposed 
and the referent groups in tests mainly involving execu-
tive functions, short time memory (BAMT test, FT test 
and DS Inverse) and for all the psychiatric symptoms 
measured by the POMS test.
These results are consistent with previous studies. A 
cross-sectional analysis of 107 occupationally exposed 
individuals showed increased rates of depression, con-
fusion, anger, fatigue, and tension as measured by the 
POMS test among those with blood levels >  40  μg/
dL  [29]; authors found that cumulative measures of 
blood lead levels in currently exposed lead workers were 
associated with tension, anxiety, hostility and depres-
sion measured by the POMS questionnaire. Lindgren et 
al.  [30] examined the POMS factor structure in retired 
lead smelter workers and showed that the resulting “gen-
eral distress” factor was significantly related to cumula-
tive exposure but not to current PbB level. Psychiatric 
symptoms (as measured by POMS), were positively as-
sociated with both the risk of Alzheimer diseases and 
a steeper rate of cognitive decline  [31]. Because late 
life symptoms of depression are closely associated with 
dementia, investigators have put forth a number of hy-
potheses that suggesting that depression a) may be a 
risk factor for cognitive decline, b) has risk factors in 
common with dementia c) is an early reaction to declin-
ing cognition and d) influences the threshold at which 
dementia emerges. The exact temporal and mechanistic 
relation remains unclear. Regardless of the exact relation 
between depressive symptoms and cognitive function, 
however, the assessment of the impact of lead exposure 
on these outcomes is not compromised. 
The mechanism with which lead exposure affects cogni-
tion in older adults has yet to be revealed, but several 
pathways have been proposed such as lead’s impact on 
oxidative stress neural apoptosis, neurotransmitter stor-
age and release, mitochondrial damage, and hippocam-
pal changes [31-33]. Of particular relevance to MCI on 
dementia is oxidative stress, with higher levels of oxi-
dative stress markers (e.g. isoprostanes, nitrotyrosine, 
8-hydroxyguanosine, 8-hydroxyguanine) among pa-
tients with MCI and AD [34].
Although it is known to induce oxidative stress [35] the 
relationship of lead exposure with these specific mark-
ers of effect is not known; lead may also affect cognitive 
function indirectly through its effect on hypertension, 
Tab.III. Pearson correlation test between biomarkers of lead expo-
sure and effect vs seniority and Hb.
PbB ALAD ZPP
Hb 0.153 -0.459* -0.264
Seniority -0.354** 0.076 -0.320**
* p < 0.01  **p < 0.05
Tab. IV. Ordinal Logistic Regression between biomarkers of Pb expo-
sure and effect vs neurobehavioral variables.
PbB ALAD ZPP
BAMT -0.223 * 0.025 -0.018
FINGER -0.008 -0.149 -0.395
D Digitation 0.558* 0.068 0.401*
I Digitation 0.031 0.032 0.002
* p < 0.005
Tab.  V. Poisson regression coefficients between biomarkers of Pb 




T *0.011 0.004 *0.007
D *0.012 *0.017 *0.008
A 0.001 0.010 0.004
V 0.006 0.002 0.003
S -00.001 0.004 0.002
C 0.003 0.005 0.002
* p < 0.005
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which is increasingly being recognized as a target for 
the prevention of dementias.
According to the recent scientific literature on this topic 
our results support the hypothesis that increased blood 
lead levels can also be associated with measurable neu-
rocognitive abnormalities. From a neurobiological point 
of view, it is of great interest that neuropsychological ef-
fects may occur at concentrations several orders of mag-
nitude below the clinical threshold for acute lead poison-
ing [36-38]. It could therefore be argued that there is no 
“safe” level for the adverse effects of lead on neuronal 
functioning and that these can only be measured using 
neuropsychological tests.
There are some limitations of our study that should be 
pointed out. For example a variety of factors can influ-
ence a person’s susceptibility, such socioeconomic sta-
tus, genetic factors and it cannot be determined from our 
data to which extent these factors influenced test results. 
Despite these limitations, however, these findings were 
consistent with those of previous studies; anyway, the 
present report suggests the need to define an occupa-
tional exposure limit for PbB lower than 30 µg/dL [39].
Acknowledgements
All Authors revised the manuscript and gave their 
contribution to improve the paper. All authors 
read and approved the final manuscript. The Authors 
have no conflict of interest to declare.
Authors' contributions
C.F. developed and planned the whole study by coordi-
nating the various stages of research.
S.G. performed the medical examination of subjects. 
A.A. made data processing and statistical analysis. 
C.C. has performed the sampling and laboratory analysis 
of the exposed and control groups.
E.M. has chosen, administered and rated the psycho-
diagnostic protocol.
References
[1] Mason LH, Harp JP, Han DY. Pb neurotoxicity: neuropsycholog-
ical effects of lead toxicity. Biomed Res Int 2014;2014:840547. 
doi: 10.1155/2014/840547.
[2] Schwartz J. Low-level lead exposure and children’s IQ: a meta-
analysis and search for a threshold. Environ Res 1994;65(1):42-
55. doi: 10.1006/enrs.1994.1020.
[3] Koller K, Brown T, Spurgeon A, Levy L. Recent develop-
ments in low-level lead exposure and intellectual impairment 
in children. Environ Health Perspect 2004;112(9):987-94. doi: 
10.1289/ehp.6941.
[4] Onalaja AO, Claudio L. Genetic susceptibility to lead poison-
ing. Environ Health Perspect 2000 Mar;108(Suppl 1):23-8.
[5] Balbus-Kornfeld JM, Stewart W, Bolla KI, Schwartz BS. Cu-
mulative exposure to inorganic lead and neurobehavioural test 
performance in adults: an epidemiological review. Occup Envi-
ron Med 1995;52(1):2-12.
[6] Goodman M, LaVerda N, Clarke C, Foster ED, Iannuzzi J, 
Mandel J. Neurobehavioural testing in workers occupationally 
exposed to lead: systematic review and meta-analysis of publi-
cations. Occup Environ Med 2002;59(4):217-23. doi:10.1136/
oem.59.4.217.
[7] Meyer-Baron M, Seeber A. A meta-analysis for neurobehav-
ioural results due to occupational lead exposure with blood lead 
concentrations < 70 microg/100 ml. Arch Toxicol 2000;73(10-
11):510-8.
[8] Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joan-
ette Y, Bocti C, Drolet V, Kirk J, Freedman M, Bergman H. 
Diagnosis and treatment of dementia: 3. Mild cognitive im-
pairment and cognitive impairment without dementia. CMAJ 
2008;178(10):1273-85. doi: 10.1503/cmaj.070797.
[9] Weisskopf MG, Proctor SP, Wright RO, Schwartz J, Spiro A 
3rd, Sparrow D, Nie H, Hu H. Cumulative lead exposure and 
cognitive performance among elderly men. Epidemiology 
2007;18(1):59-66. doi: 10.1097/01.ede.0000248237.35363.29.
[10] Basha MR, Murali M, Siddiqi HK, Ghosal K, Siddiqi OK, 
Lashuel HA, Ge YW, Lahiri DK, Zawia NH. Lead (Pb) expo-
sure and its effect on APP proteolysis and Abeta aggregation. 
FASEB J 2005;19(14):2083-4. doi: 10.1096/fj.05-4375fje.
[11] Sun L, Zhou XL, Yi HP, Jiang SJ, Yuan H. Lead-induced 
morphological changes and amyloid precursor protein ac-
cumulation in adult rat hippocampus. Biotech Histochem 
2014;89(7):513-7. doi: 10.3109/10520295.2014.904926. 
[12] Wu J, Basha MR, Brock B, Cox DP, Cardozo-Pelaez F, McPher-
son CA, Harry J, Rice DC, Maloney B, Chen D, Lahiri DK, 
Zawia NH. Alzheimer’s disease (AD)-like pathology in aged 
monkeys after infantile exposure to environmental metal lead 
(Pb): evidence for a developmental origin and environmental 
link for AD. J Neurosci 2008;28(1):3-9. doi: 10.1523/JNEURO-
SCI.4405-07.2008.
[13] Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead 
exposure and cardiovascular disease-a systematic review. Envi-
ron Health Perspect 2007;115(3):472-82. doi: 10.1289/ehp.9785.
[14] Vaziri ND. Mechanisms of lead-induced hypertension and 
cardiovascular disease. Am J Physiol Heart Circ Physiol 
2008;295(2):H454-65. doi: 10.1152/ajpheart.00158.2008.
[15] Fenga C, Cacciola A, Martino LB, Calderaro SR, Di Nola C, 
Verzera A, Trimarchi G, Germanò D. Relationship of blood 
lead levels to blood pressure in exhaust battery storage work-
ers. Ind Health 2006;44(2):304-9. http://doi.org/10.2486/ind-
health.44.304.
[16] Rapisarda V, Ledda C, Ferrante M, Fiore M, Cocuzza S, Brac-
ci M, Fenga C. Blood pressure and occupational exposure to 
noise and lead (Pb): a cross-sectional study. Toxicol Ind Health 
2016;32(10):1729-36. doi: 10.1177/0748233715576616.
[17] Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight 
C, Sadovnick AD. Diagnosis and treatment of dementia: 1. 
Risk assessment and primary prevention of Alzheimer disease. 
CMAJ 2008;178(5):548-56. doi: 10.1503/cmaj.070796.
[18] Reddy GR, Devi BC, Chetty CS. Developmental lead neurotox-
icity: alterations in brain cholinergic system. Neurotoxicology 
2007;28(2):402-7. doi.org/10.1016/j.neuro.2006.03.018.
[19] Wang L, Luo L, Luo YY, Gu Y, Ruan DY. Effects of Pb2+ on 
muscarinic modulation of glutamatergic synaptic transmission 
in rat hippocampal CA1 area. Neurotoxicology 2007;28(3):499-
507. doi: 10.1016/j.neuro.2006.11.003.
[20] ACGIH. 2015 TLVs® and BEIs. Cincinnati, OH: American 
Conference of Governmental Industrial Hygienists; 2015. 
[21] Lebel J, Mergler D, Branches F, Lucotte M, Amorim M, Lar-
ribe F, Dolbec J. Neurotoxic effects of low-level methylmer-
cury contamination in the Amazonian Basin. Environ Res 
1998;79(1):20-32. doi: 10.1006/enrs.1998.3846.
[22] Rohlman DS, Lucchini R, Anger WK, Bellinger DC, van Thriel 
C. Neurobehavioral testing in human risk assessment. Neurotox-
icology 2008;29(3):556-67. doi: 10.1016/j.neuro.2008.04.003.
C. FENGA ET AL.
E210
[23] Wechsler D. WAIS - Scala d’intelligenza Wechsler per adulti. 
Firenze: Organizzazioni Speciali 1999.
[24] McNair DM, Lorr M, Droppleman LF. POMS - Profile of Mood 
States. Firenze: Organizzazioni Speciali 1991.
[25] Pesarin F. Multivariate permutation test: with applications in 
biostatistics. New York: Wiley 2001.
[26] Griffin D, Gonzalez R. Correlational analysis of dyad-level 
data in the exchangeable case. Psychol Bull 1995;118:430-9.
[27] Kleinbaum DG. Logistic regression: a self-learning test. New 
York: Springer 1994.
[28] Mc Cullagh P, Nelder JA. Generalized Linear Models. 2nd ed. 
USA: Chapman and Hall CRC 1989.
[29] Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, 
Schneider JS, Bach J, Pilat J, Beckett LA, Arnold SE, Evans 
DA, Bennett DA. Depressive symptoms, cognitive decline, and 
risk of AD in older persons. Neurology 2002;59:364-70.
[30] Lindgren KN, Masten VL, Ford DP, Bleecker ML. Relation of 
cumulative exposure to inorganic lead and neuropsychological 
test performance. Occup Environ Med 1996;53:472-7.
[31] Shih RA, Hu H, Weisskopf MG, Schwartz BS. Cumulative lead 
dose and cognitive function in adults: a review of studies that 
measured both blood lead and bone lead. Environ Health Per-
spect. 2007;115(3):483-92. doi: 10.1289/ehp.9786.
[32] Weuve J, Korrick SA, Weisskopf MG, Ryan LM, Schwartz J, 
Nie H, Grodstein F, Hu H. Cumulative exposure to lead in rela-
tion to cognitive function in older women. Environ Health Per-
spect 2009;117(4):574-80. doi: 10.1289/ehp.11846.
[33] White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni 
E, Zawia NH, Virgolini M, Rossi-George A, Lasley SM, Qian 
YC, Basha MR. New and evolving concepts in the neurotoxi-
cology of lead. Toxicol Appl Pharmacol 2007;225(1):1-27. doi: 
10.1016/j.taap.2007.08.001.
[34] Praticò D. Oxidative stress hypothesis in Alzheimer’s disease: 
a reappraisal. Trends Pharmacol Sci 2008;29(12):609-15. doi: 
10.1016/j.tips.2008.09.001.
[35] Ahamed M, Siddiqui MK. Low level lead exposure and oxida-
tive stress: current opinions. Clin Chim Acta 2007;383(1-2):57-
64. doi: 10.1016/j.cca.2007.04.024.
[36] Murata K, Iwata T, Dakeishi M, Karita K. Lead toxicity: does 
the critical level of lead resulting in adverse effects differ be-
tween adults and children? J Occup Health 2009;51(1):1-12. 
http://doi.org/10.1539/joh.K8003.
[37] Counter SA, Buchanan LH, Ortega F. Neurocognitive screen-
ing of lead-exposed andean adolescents and young adults. 
J Toxicol Environ Health A 2009;72(10):625-32. doi: 
10.1080/15287390902769410.
[38] Lucchini RG, Zoni S, Guazzetti S, Bontempi E, Micheletti S, 
Broberg K, Parrinello G, Smith DR. Inverse association of intel-
lectual function with very low blood lead but not with manga-
nese exposure in Italian adolescents. Environ Res 2012;118:65-
71. doi: 10.1016/j.envres.2012.08.003.
[39] Landrigan P, Nordberg M, Lucchini R, Nordberg G, Grandjean 
P, Iregren A, Alessio L; International Workshop on neurotoxic 
metals: lead, mercury, and manganese - from research to pre-
vention (NTOXMET). The Declaration of Brescia on preven-
tion of the neurotoxicity of metals June 18, 2006. Am J Ind 
Med.2007;50(10):709-11. doi: 10.1002/ajim.20404.
n Received on August 14, 2015. Accepted on November 2, 2016.
n Correspondence: Elvira Micali, University of Messina, University 
Hospital of Messina, via S. Sebastiano 24, 98122 Messina, Italy - 
Tel. +39 090 2217197 - Fax +39 090 2930337 - E-mail: emicali@
unime.it
